Benlysta 49401-0101-01
Generic: Belimumab
- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 10, 2011
- Listing Expires
- December 31, 2027
- Application
- BLA125370
Need to source Benlysta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Belimumab | 120 mg/1.5mL |
Drug Class
B Lymphocyte Stimulator-specific Inhibitor [EPC]B Lymphocyte Stimulator-directed Antibody Interactions [MoA]B Lymphocyte Stimulator-specific Inhibitor [EPC]
Selected Package
49401-0101-01Selected1 VIAL in 1 CARTON (49401-101-01) / 1.5 mL in 1 VIAL